Certus work alongside an extensive selection of the Healthcare sectors leading investment funds. Our investor reach extends to over 520 International Healthcare focused PE Funds, Family Offices, Big Pharma Venture Funds and Industry Corporates which, based on current industry research, is over 90% of total corporate and institutional investors active in the Healthcare sector.
We support Capital Raisers seeking equity capital and M&A across the full value chain of the Healthcare sector.
Genomics based personalized cancer treatment company.
US Pharma developing FDA breakthrough drug for suicidal depression & PTSD.
Privately held DNA testing company, helping to improve cellular health.
US based MedTech developing treatments for venous reflux disease.
Personalized AI-powered health information company focused on chronic illness.
US Therapeutics company targeting human obesity.
US dietary supplement company focused on Chronic Kidney disease.
US Biopharma company focused on autoinflammatory orphan diseases.
US MedTech producing Extra Corporeal Membrane Oxygenation technology.
US Pharma developing patented new class of prn medications for acute anxiety.
“We have thoroughly enjoyed working with Adam Sommerfeld and Certus. Certus has undertaken a comprehensive outreach to venture funds, sovereign wealth funds and family offices and has been able to arrange initial meetings that would have been impossible for us if we were cold calling. Once initial contacts are arranged, Certus has managed the entire process, requiring very little of our management’s time. Overall, it has been a great experience”